BluePath Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
58,864
+15,599
+36% +$419K 1.12% 16
2026
Q1
$898K Buy
43,265
+17,397
+67% +$411K 0.62% 71
2025
Q4
$840K Buy
25,868
+3,084
+14% +$132K 0.57% 73
2025
Q3
$1.29M Buy
22,784
+1,951
+9% +$100K 0.95% 27
2025
Q2
$1.04M Buy
20,833
+342
+2% +$15.5K 0.91% 31
2025
Q1
$606K Buy
+20,491
New +$761K 0.63% 52

Other funds holding HIMS

BluePath Capital Management's HIMS Position: Q2 2026 in Review

BluePath Capital Management increased its Hims & Hers Health (HIMS) stake by 36% in Q2 2026, buying an estimated $419K and bringing the position to 58,864 shares worth $2.04M. The position accounts for 1.12% of the portfolio, ranked #16.

BluePath Capital Management first reported a position in HIMS in Q1 2025 and has held it in 6 quarters since. 92 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • BluePath Capital Management held 58,864 shares of Hims & Hers Health worth $2.04M as of Q2 2026.
  • BluePath Capital Management bought 15,599 Hims & Hers Health shares in Q2 2026, an estimated $419K.
  • Hims & Hers Health made up 1.12% of BluePath Capital Management's portfolio in Q2 2026, its #16 holding.
  • BluePath Capital Management first reported a position in Hims & Hers Health in Q1 2025 and has held it in 6 quarters since.
  • 92 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.